跳转至内容
Merck
CN

Quantification and stability of salbutamol in human urine.

Journal of separation science (2004-09-01)
Guro Forsdahl, Günter Gmeiner
摘要

A sensitive method for the quantification of free salbutamol in human urine is described. Sample clean up is performed using SPE on a mixed phase extraction column. Derivatisation is performed with N-methyl-N-trimethylsilyltrifluoroacetamide (MSTFA) and the extract is analysed by GC-MS. The method was found to be suitable for use in the doping field, where a cut-off limit of 1 microg salbutamol/mL urine is set by the International Olympic Committee (IOC) and approved by the World Anti-Doping Agency (WADA). Above that value a doping violation occurs. In addition, the stability of salbutamol in human urine has been evaluated.

材料
产品编号
品牌
产品描述

Supelco
N-甲基-N-(三甲基硅烷基)三氟乙酰胺, derivatization grade (GC derivatization), LiChropur, ≥98.5%
Supelco
N-甲基-N-(三甲基硅烷基)三氟乙酰胺, synthesis grade
Supelco
N-甲基-N-(三甲基硅烷基)三氟乙酰胺, BioReagent, for silylations, LiChropur
Supelco
含有1%三甲基氯硅烷的N-甲基-N-(三甲基甲硅烷基)三氟乙酰胺, derivatization grade (GC derivatization), LiChropur
Supelco
MSTFA 试剂, ampule of 10 × 1.2 mL, analytical standard, Cerilliant®